Welcome to our dedicated page for Cross Ctry Healthcare SEC filings (Ticker: CCRN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Cross Country Healthcare, Inc. (CCRN) SEC filings page on Stock Titan provides centralized access to the company’s public filings with the U.S. Securities and Exchange Commission. As a Nasdaq-listed issuer, Cross Country Healthcare submits a range of documents that detail its financial condition, governance, and material corporate events.
Investors can use this page to locate current and historical reports such as annual reports on Form 10‑K and quarterly updates on Form 10‑Q, which the company references in its proxy materials and earnings communications. These reports typically include audited or reviewed financial statements, segment information for Nurse and Allied Staffing and Physician Staffing, discussions of Homecare and Education staffing activities, and management’s analysis of operational efficiency, technology investments, and market conditions.
The filings page also surfaces current reports on Form 8‑K, which Cross Country Healthcare uses to disclose significant events. Recent examples include 8‑Ks reporting quarterly financial results furnished under Item 2.02, updates on the Agreement and Plan of Merger with Aya Healthcare and its termination, the automatic extension of the merger agreement end date, the scheduling of the 2025 Annual Meeting of Stockholders, and the CEO transition in which co‑founder and Chairman Kevin C. Clark was appointed President and Chief Executive Officer.
In addition, users can review the company’s definitive proxy statements on Schedule 14A, which describe board composition, director qualifications, executive compensation, and key proposals submitted to stockholders. These documents also summarize strategic priorities such as strengthening the operational foundation, advancing technology capabilities, and addressing workforce needs across healthcare, homecare, and education markets.
Stock Titan enhances these filings with AI-powered summaries that explain the key points of lengthy documents, helping readers quickly understand the implications of new 10‑K, 10‑Q, 8‑K, and proxy filings. Real-time updates from EDGAR, combined with simplified explanations of complex disclosures, make it easier to track Cross Country Healthcare’s regulatory reporting and governance developments, including items related to potential transactions, capital allocation, and leadership changes.
Cross Country Healthcare reported first-quarter 2026 results and highlighted a pending cash merger. Revenue from services was $241.1 million, down 17.8% from $293.4 million a year earlier, mainly from lower volumes in both operating segments. The company posted a net loss attributable to common stockholders of $4.3 million, or $0.14 per share, compared with a $0.5 million loss, or $0.02 per share, in the prior-year quarter.
Nurse and Allied Staffing generated $201.4 million of revenue, while Physician Staffing contributed $39.6 million, with segment contribution margins compressing in both areas. Cash and cash equivalents were $105.6 million and there were no borrowings under the $300 million asset-based credit facility, with $109.3 million of borrowing base availability. The company repurchased 657,653 shares for $5.8 million under its stock repurchase program. After quarter-end, Cross Country entered into a definitive Agreement and Plan of Merger under which its common shares will be converted into $13.25 in cash, and the company is expected to become a wholly owned subsidiary of KL Criss Cross Intermediate, LLC upon closing.
Cross Country Healthcare, Inc. reported first quarter 2026 revenue of $241.1 million, down 18% from a year earlier but up 2% from the prior quarter, reflecting modest sequential improvement after a sharp industry slowdown. Consolidated gross profit margin was 19.7%, slightly below both prior year and prior quarter levels.
The company posted a net loss attributable to common stockholders of $4.3 million, versus a $0.5 million loss a year ago and an $82.9 million loss in the prior quarter. Adjusted EBITDA was $3.9 million, or 1.6% of revenue. Cross Country ended the quarter with $105.6 million in cash, no debt, and repurchased about 0.7 million shares for $5.8 million. The release notes a pending merger with KL Criss Cross Intermediate, after which the stock is expected to be delisted and deregistered.
Cross Country Healthcare, Inc. agreed to be acquired by Knox Lane in an all-cash merger. Stockholders are expected to receive $13.25 per share in cash, valuing the deal at about $437 million and reflecting premiums of roughly 31% to the last close and 45% to the 90-day volume-weighted average price.
The merger must be approved by a majority of Cross Country stockholders and clear antitrust and other customary conditions. If completed, Cross Country will become a wholly owned subsidiary of Knox Lane, its shares will be delisted and deregistered, and the company has canceled its Q1 2026 earnings call and 2026 annual meeting in light of the proposed transaction.
Cross Country Healthcare, Inc. announced it will hold a quarterly conference call to discuss its first quarter 2026 financial results on Thursday, May 7, 2026 at 5:00 p.m. Eastern Time. The company intends to issue its earnings press release after the market close that same day.
The call will be available via live webcast on the company’s investor relations website and by telephone using the provided U.S. and international dial-in numbers and passcode. Telephone and webcast replays will be accessible from May 7 through May 21, 2026. The filing also reiterates that the furnished press release is not deemed filed for liability purposes under the Exchange Act.
Dimensional Fund Advisors amended a Schedule 13G to report beneficial ownership of 1,609,925 shares of Cross Country Healthcare Inc common stock, representing 5.0% of the class as of 03/31/2026. The filing states Dimensional acts as adviser to funds that own the shares and disclaims beneficial ownership; voting and dispositive powers are held on behalf of those Funds.
CROSS COUNTRY HEALTHCARE INC Group President, Delivery Marc S. Krug reported equity compensation activity involving the company’s common stock. He received a grant of 21,024 restricted shares that vest in three substantially equal installments on March 31, 2027, March 31, 2028 and March 31, 2029.
On the same date, 1,123 shares and 1,339 shares were withheld at a price of $9.40 per share to cover tax withholding obligations for restricted stock that vested on March 31, 2026. After these transactions, Krug directly owns 77,232 common shares.
CROSS COUNTRY HEALTHCARE INC Chief Operating Officer Amiee Lin Hawkins reported routine equity compensation and related tax withholding in company stock. She received a grant of 15,958 restricted shares of common stock, which vest in three substantially equal installments on March 31, 2027, March 31, 2028 and March 31, 2029. To cover tax obligations on restricted stock that vested on March 31, 2026, a total of 1,278 shares were withheld at a price of $9.40 per share through two transactions. After these transactions, she directly holds 43,953 shares of common stock.
Clark Kevin Cronin reported acquisition or exercise transactions in this Form 4 filing.
Cross Country Healthcare Chief Executive Officer Kevin Cronin reported an award of 138,963 shares of restricted common stock at no purchase price. These shares vest in three substantially equal installments on March 31, 2027, March 31, 2028 and March 31, 2029.
Following the award, he holds 948,133 shares directly. A separate line reflects 3,961 shares held indirectly by his spouse, for which he disclaims beneficial ownership except for any pecuniary interest.
CROSS COUNTRY HEALTHCARE INC Chief Financial Officer William J. Burns reported routine equity compensation and related tax withholding transactions in company stock. He received a grant of 47,873 restricted shares of common stock at no cost, which vest in three substantially equal installments on March 31, 2027, March 31, 2028, and March 31, 2029.
To cover tax obligations on restricted stock that vested on March 31, 2026, 2,423 shares and 2,890 shares of common stock were withheld at a value of $9.40 per share. After these transactions, Burns directly holds 336,438 shares of CROSS COUNTRY HEALTHCARE INC common stock.
Cross Country Healthcare General Counsel Susan E. Ball reported routine equity compensation and related tax withholding transactions. On March 31, 2026, she received a grant of 33,644 shares of common stock at no cost, described as restricted shares that will vest in three substantially equal installments on March 31, 2027, March 31, 2028, and March 31, 2029.
On the same date, 1,689 and 2,014 shares were withheld at $9.40 per share to satisfy tax withholding obligations for restricted stock that vested on March 31, 2026. After these transactions, she directly holds 241,777 shares of Cross Country Healthcare common stock.